MYC Is Amplified in BRCA1-Associated Breast Cancers

Clinical Cancer Research

Volumn 10, Issue 2, 2004, Pages 499-507

  Grushko, Tatyana A ^a   Dignam, James J ^a   Das, Soma ^a   Blackwood, Anne M ^b   Perou, Charles M ^d   Ridderstråle, Karin K ^a   Anderson, Kristin N ^a   Wei, Min Jie ^a   Adams, April J ^a   Hagos, Fitsum G ^a   Sveen, Lise ^a   Lynch, Henry T ^e   Weber, Barbara L ^b,c   Olopade, Olufunmilayo I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CLINICAL ARTICLE; DNA METHYLATION; DNA PROBE; EARLY CANCER; FAMILIAL CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVITY; GENE AMPLIFICATION; GENE DYSREGULATION; GENE MUTATION; GERM LINE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ONCOGENE MYC; PHENOTYPE; PRIORITY JOURNAL; SPORADIC CANCER; STATISTICAL MODEL; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE;

ADULT; ALLELES; BREAST NEOPLASMS; CELL DIVISION; DISEASE PROGRESSION; DNA METHYLATION; GENES, BRCA1; GENOTYPE; GERM-LINE MUTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC;

EID: 10744222271     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0976-03     Document Type: Article

References (35)

1. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., and Ding, W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Wash. DC), 266: 66-71, 1994.
2. Arver, B., Du, Q., Chen, J., Luo, L., and Lindblom, A. Hereditary breast cancer: a review. Semin. Cancer Biol., 10: 271-288, 2000.
3. Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 108: 171-182, 2002.
4. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Kallioniemi, O. P., Wilfond, B., Borg, A., and Trent, J. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med., 344: 539-548, 2001.
5. van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-536, 2002.
6. Catteau, A., and Morris, J. R. BRCA1 methylation: a significant role un tumour development? Semin. Cancer Biol., 12: 359-371, 2002.
7. Esteller, M., Silva, J. M., Dominguez, G., Bonilla, F., Matias-Guiu, X., Lerma, E., Bussaglia, E., Prat, J., Harkes, I. C., Repasky, E. A., Gabrielson, E., Schutte, M., Baylin, S. B., and Herman, J. G. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. (Bethesda), 92: 564-569, 2000.
8. Grushko, T. A., Blackwood, M. A., Schumm, P. L., Hagos, F. G., Adeyanju, M. O., Feldman, M. D., Sanders, M. O., Weber, B. L., and Olopade, O. I. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res., 62: 1481-1488, 2002.
9. Croce, C. M. Molecular biology of lymphomas. Semin. Oncol., 20: 31-46, 1993.
10. Liao, D. J., and Dickson, R. B. c-Myc in breast cancer. Endocr.-Relat. Cancer (Phila.), 7: 143-164, 2000.
11. Jain, A., Chin, K., Borresen-Dale, A. L., Erikstein, B. K., Eynstein Lonning, P., Kaaresen, R., and Gray, J. W. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc. Natl. Acad. Sci. USA, 98: 7952-7957, 2001.
12. Olopade, O. I., and Grushko, T. A. Gene-expression profiles in hereditary breast cancer. [letter; comment.] (Published erratum appears in N. Engl. J. Med., 345: 628, 2001). N. Engl. J. Med., 344: 2028-2029, 2001.
13. Olopade, O. I., and Grushko, T. A. Gene-expression profiles in hereditary breast cancer. [letter; comment.] (Published erratum appears in N. Engl. J. Med., 345: 628, 2001). N. Engl. J. Med., 344: 2028-2029, 2001.
14. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
15. Xu, C. F., Brown, M. A., Chambers, J. A., Griffiths, B., Nicolai, H., and Solomon, E. Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum. Mol. Genet., 4: 2259-2264, 1995.
16. Brown, M. A., Xu, C. F., Nicolai, H., Griffiths, B., Chambers, J. A., Black, D., and Solomon, E. The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene, 12: 2507-2513, 1996.
17. Wang, Q., Zhang, H., Kajino, K., and Green, M. I. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene, 17: 1939-1948, 1998.
18. Janocko, L. E., Brown, K. A., Smith, C. A., Gu, L. P., Pollice, A. A., Singh, S. G., Julian, T., Wolmark, N., Sweeney, L., Silverman, J. F., and Shackney, S. E. Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers. Cytometry, 46: 136-149, 2001.
19. Nass, S. J., and Dickson, R. B. Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res. Treat., 44: 1-22, 1997.
20. Rummukainen, J. K., Salminen, T., Lundin, J., Joensuu, H., and Isola, J. J. Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples. Lab. Investig., 81: 1545-1551, 2001.
21. Rummukainen, J. K., Salminen, T., Lundin, J., Kytola, S., Joensuu, H., and Isola, J. J. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array. Mod. Pathol., 14: 1030-1035, 2001.
22. Persons, D. L., Borelli, K. A., and Hsu, P. H. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. Mod. Pathol., 10: 720-727, 1997.
23. Deng, C. X., and Brodie, S. G. Roles of BRCA1 and its interacting proteins. Bioessays, 22: 728-737, 2000.
24. Kainu, T., Juo, S. H., Desper, R., Schaffer, A. A., Gillanders, E., Rozenblum, E., Freas-Lutz, D., Weaver, D., Stephan, D., Bailey-Wilson, J., Kallioniemi, O. P., Tirkkonen, M., Syrjakoski, K., Kuukasjarvi, T., Koivisto, P., Karhu, R., Holli, K., Arason, A., Johannesdottir, G., Bergthorsson, J. T., Johannsdottir, H., Egilsson, V., Barkardottir, R. B., Johannsson, and Okuda, S. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc. Natl. Acad. Sci. USA, 97: 9603-9608, 2000.
25. Tirkkonen, M., Johannsson, O., Agnarsson, B. A., Olsson, H., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J., Barkardottir, R. B., Borg, A., and Kallioniemi, O. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57: 1222-1227, 1997.
26. Brodie, S. G., Xu, X., Qiao, W., Li, W. M., Cao, L., and Deng, C. X. Multiple genetic changes are associated with mammary tumorigenesis in Brcal conditional knockout mice. Oncogene, 20: 7514-7523, 2001.
27. Weaver, Z., Montagna, C., Xu, X., Howard, T., Gadina, M., Brodie, S. G., Deng, C. X., and Ried, T. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene, 21: 5097-5107, 2002.
28. Hedenfalk, I., Ringner, M., Ben-Dor, A., Yakhini, Z., Chen, Y., Chebil, G., Ach, R., Loman, N., Olsson, H., Meltzer, P., Borg, A., and Trent, J. Molecular classification of familiar non-BRCA1-BRCA2 breast cancer. Proc. Natl. Acad. Sci. USA, 100: 2532-2537, 2003.
29. Li, H., Lee, T. H., and Avraham, H. A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. J. Biol. Chem., 277: 20965-20973, 2002.
30. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A. L., Brown, P. O., and Botstein, D. Molecular portraits of human breast tumours. Nature (Lond.), 406: 747-752, 2000.
31. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lonning, P., and Borresen-Dale, A. L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA, 98: 10869-10874, 2001.
32. Schraml, P., Kononen, J., Bubendorf, L., Moch, H., Bissig, H., Nocito, A., Mihatsch, M. J., Kallioniemi, O. P., and Sauter, G. Tissue microarrays for gene amplification surveys in many different tumor types. Clin. Cancer Res., 5: 1966-1975, 1999.
33. Visscher, D. W., Wallis, T., Awussah, S., Mohamed, A., and Crissman, J. D. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics. Genes, Chromosomes Cancer, 18: 1-7, 1997.
34. Fiche, M., Avet-Loiseau, H., Maugard, C. M., Sagan, C., Heymann, M. F., Leblanc, M., Classe, J. M., Fumoleau, P., Dravet, F., Mahe, M., and Dutrillaux, B. Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: relation to morphology, cell proliferation and expression of breast cancer-related genes. Int. J. Cancer (Pred. Oncol.), 89: 403-410, 2000.
35. Heselmeyer-Haddad, K., Chaudhri, N., Stoltzfus, P., Cheng, J. C., Wilber, K., Morrison, L., Auer, G., and Ried, T. Detection of chromosomal aneuploidies and gene copy number changes in fine needle aspirates is a specific, sensitive, and objective genetic test for the diagnosis of breast cancer. Cancer Res., 62: 2365-2369, 2002.